6 Results for "

HFCS

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "HFCS" in MCE Product Catalog:

Cat. No.: HY-P991401

Target:  

TNF Receptor

Research Areas:  

Inflammation/Immunology

GSK2862277 is a human monoclonal antibody (mAb) targeting TNFRSF1A. GSK2862277 increases neutrophil extracellular trap formation and alveolar macrophage phagocytosis. GSK2862277 can be used in Acute lung injury and Acute Respiratory Distress Syndrome (ARDS) research. Recommended isotype control: VHH-hFc .
Cat. No.: HY-156010
CAS No.: 2682078-97-1
Purity:  99.57%
Target:  

PPAR

Research Areas:  

Metabolic Disease

PPARγ-IN-2 (Compound 5a) is a PPARγ inhibitor. PPARγ-IN-2 inhibits TG accumulation in 3T3-L1 preadipocytes (EC50: 0.106 μM). PPARγ-IN-2 inhibits high-cholesterol diet (HFC)-induced obesity and related metabolic syndrome, and reduces lipid accumulation in adipose tissue .
Cat. No.: HY-W267897
CAS No.: 220001-53-6
Synonyms: 7-BFC
Target:  

Cytochrome P450

Research Areas:  

Others

7-Benzyloxy-4-(trifluoromethyl)coumarin (7-BFC) is a coumarin fluorescent substrate. 7-Benzyloxy-4-(trifluoromethyl)coumarin is a substrate for cDNA-expressed CYP1A2 and CYP3A4 and is metabolized to 7-hydroxy-4-trifluoromethylcoumarin (HFC). 7-Benzyloxy-4-(trifluoromethyl)coumarin is used for rapid CYP isoform metabolism and inhibition screening studies .
Cat. No.: HY-145775
CAS No.: 1425051-22-4
Target:  

Fc Receptor (FcR)

Research Areas:  

Inflammation/Immunology

hIgG–hFc receptor-IN-1 (comp 66) is a human immunoglobulin G–human neonatal Fc receptor (hIgG–hFcRn) protein-protein interaction inhibitor, with an IC50 of 2 μM .
Anti-hFc1 aptamer sodium
0 Images
RNA, 5'-GGAGGfUGfCfUfCfCGAAAGGAAfCfUfCfCA-3', sodium salt
Cat. No.: HY-177812
Anti-hFc1 aptamer sodium is an RNA aptamer that targets the Fc fragment of human IgG1 (hFc1).
Cat. No.: HY-181617
CAS No.: 2281679-00-1
Synonyms: 12-hFC
Target:  

Drug Derivative

Research Areas:  

Cancer

12-Hydroxyfusicoccin (12-hFC) is a Fusicoccin (HY-122815) derivative. 12-Hydroxyfusicoccin lacks antiproliferative activity and is inactive to protein-protein interactionin and protein synthesis in cancer cells .